Hospitals News

Stay updated on hospitals with press releases highlighting industry news, trends, and innovations shaping healthcare facilities. Learn about key developments in hospital management and explore opportunities in patient care and healthcare technologies.

May 25, 2026 at 4:00 AM

Striking workers to rally outside state of the province address by Premier Houston

HALIFAX, NS--(BUSINESS WIRE)--Striking long term care workers from across Nova Scotia will be collapsing picket lines and converging outside of Premier Tim Houston’s state of the province address today. All Canadian Union of Public Employees (CUPE) members in Nova Scotia, community and political allies, as well as labour leaders will be speaking to the ‘state of long term care’ at a rally this afternoon. "It’s time our elected representatives listened to their constituents. We’re not just worke...
May 22, 2026 at 5:37 PM

AOA Statement on HHS Dismissal of USPSTF Vice Chairs

CHICAGO--(BUSINESS WIRE)--Access to evidence-based preventive services is central to delivering whole-person care and supporting long-term patient wellbeing. Representing more than 207,000 osteopathic physicians (DOs) and medical students in the U.S., we are deeply concerned by the abrupt dismissal of the United States Preventive Services Task Force (USPSTF) Vice Chairs and political interference in the USPSTF process. The USPSTF plays a critical role in healthcare coverage and access to servic...
May 22, 2026 at 2:00 PM

FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living with chronic hepatitis delta virus (HDV) infection, making it the first and only approved treatment for HDV in the United States. The FDA granted accelerated approval to Hepcludex based on reductions in HDV RNA and normalization of alanine aminotrans...
May 22, 2026 at 8:15 AM

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

GUILFORD, Conn.--(BUSINESS WIRE)--PRIME study results show bedside portable MRI cut order-to-scan time vs conventional MRI and identified critical ED findings....
May 22, 2026 at 7:47 AM

Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing authorization of Trodelvy® (sacituzumab govitecan-hziy) as a monotherapy for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy for met...
May 22, 2026 at 7:30 AM

ImmunityBio Highlights Patient Survey Data at ISPOR 2026 Showing Majority of UK Adults Living with NMIBC Favor Bladder Preservation

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced new survey data highlighting the diverse treatment preferences and decision-making priorities of patients with Bacillus Calmette–Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). The findings were presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2026, May 17–20, 2026, at the Pennsylvania Conventi...
May 21, 2026 at 5:00 PM

New ASCO and EHA 2026 Data Demonstrate Gilead and Kite’s Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology

FOSTER CITY, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that together with Kite, a Gilead company, it will present more than 25 abstracts, including six oral presentations, at the 2026 ASCO Annual Meeting (May 29 – June 2) and the 2026 EHA Congress (June 11 – 14). These presentations underscore the increasing diversity of Gilead’s oncology portfolio and pipeline reflecting a growing body of evidence across both solid tumors and hematolog...
May 21, 2026 at 5:00 PM

Flatiron Health Brings 25+ Research Acceptances and Next-Generation Capabilities to ASCO 2026

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its presence at the American Society of Clinical Oncology (ASCO) Annual Meeting happening from May 29 - June 2, 2026, in Chicago, Illinois. Flatiron's high-quality real-world data and innovative research capabilities are featured across 25+ research acceptances, including 14 Flatiron-authored poster presentations and online publications. Flatiron’s presence at ASCO 2026 closely follows the launch of Flatiron Telescope, a multi-agent ada...
May 21, 2026 at 5:00 PM

City of Hope Researchers Present Advances in Targeted Therapies, Microbiome Science and Blood Cancers at ASCO 2026

LOS ANGELES--(BUSINESS WIRE)--Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, will present new findings at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, where the cancer center will showcase 49 abstracts spanning solid tumors and blood cancers. This year’s research, to be prese...
May 21, 2026 at 1:57 PM

Number of CUPE long term care locals on strike across NS hits 35

HALIFAX, NS--(BUSINESS WIRE)--After six weeks on the picket line, long term care workers continue to show their commitment to their demands. Nearly 3,500 members of the Canadian Union of Public Employees (CUPE) have been on strike since mid April. Workers at MacGillivray Guest House in Sydney are expected to join the strike this week, bringing the total number of striking locals across Nova Scotia to 35. Represented by CUPE 1562, workers will begin their strike on May 22 at 7am at 25 Xavier Dri...
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up